80 related articles for article (PubMed ID: 20439338)
1. Justifying terminal care by 'retrospective quality-adjusted life-years'.
Cowley C
J Med Ethics; 2010 May; 36(5):290-2. PubMed ID: 20439338
[TBL] [Abstract][Full Text] [Related]
2. Composite measures for hospital quality using quality-adjusted life years.
Timbie JW; Shahian DM; Newhouse JP; Rosenthal MB; Normand SL
Stat Med; 2009 Apr; 28(8):1238-54. PubMed ID: 19184974
[TBL] [Abstract][Full Text] [Related]
3. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
4. Quality of life: the contested rhetoric of resource allocation and end-of-life decision making.
Nantais D; Kuczewski M
J Med Philos; 2004 Dec; 29(6):651-64. PubMed ID: 15590514
[TBL] [Abstract][Full Text] [Related]
5. Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control.
Schmittdiel J; Vijan S; Fireman B; Lafata JE; Oestreicher N; Selby JV
Med Care; 2007 Apr; 45(4):315-21. PubMed ID: 17496715
[TBL] [Abstract][Full Text] [Related]
6. Equity weights in the allocation of health care: the rank-dependent QALY model.
Bleichrodt H; Diecidue E; Quiggin J
J Health Econ; 2004 Jan; 23(1):157-71. PubMed ID: 15154692
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life after stroke: review of the literature and implications for future research.
Tseng MC; Lin HJ
Acta Neurol Taiwan; 2007 Mar; 16(1):7-12. PubMed ID: 17486727
[TBL] [Abstract][Full Text] [Related]
8. [Key ethic discussions in hospice/palliative care].
Jusić A
Acta Med Croatica; 2008 Dec; 62(5):447-54. PubMed ID: 19382626
[TBL] [Abstract][Full Text] [Related]
9. Death, time and the theory of relativity.
Chochinov HM
J Pain Symptom Manage; 2011 Sep; 42(3):460-3. PubMed ID: 21276702
[TBL] [Abstract][Full Text] [Related]
10. Important aspects of end-of-life care among veterans: implications for measurement and quality improvement.
Casarett D; Pickard A; Amos Bailey F; Ritchie C; Furman C; Rosenfeld K; Shreve S; Shea JA
J Pain Symptom Manage; 2008 Feb; 35(2):115-25. PubMed ID: 18053680
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival, quality of life, and quality-adjusted life-years among critically ill elderly patients.
Kaarlola A; Tallgren M; Pettilä V
Crit Care Med; 2006 Aug; 34(8):2120-6. PubMed ID: 16763517
[TBL] [Abstract][Full Text] [Related]
12. Six Sigma: not for the faint of heart.
Benedetto AR
Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
[TBL] [Abstract][Full Text] [Related]
13. Quality-adjusted life years: how useful in medico economic studies.
Brauer CA; Neumann PJ
Fundam Clin Pharmacol; 2005 Dec; 19(6):603-7. PubMed ID: 16313271
[TBL] [Abstract][Full Text] [Related]
14. Assuring quality end-of-life care: imperative to expand the evidence base in concert with growth of the field.
Kutner JS
J Am Geriatr Soc; 2008 Jan; 56(1):160-2. PubMed ID: 18047495
[No Abstract] [Full Text] [Related]
15. Improving care at the end of life.
Hume M
Qual Lett Healthc Lead; 1998 Oct; 10(10):2-10. PubMed ID: 10185743
[TBL] [Abstract][Full Text] [Related]
16. Measuring outcomes in palliative care: limitations of QALYs and the road to PalYs.
Normand C
J Pain Symptom Manage; 2009 Jul; 38(1):27-31. PubMed ID: 19615624
[TBL] [Abstract][Full Text] [Related]
17. A cost-utility analysis of chronic spinal pain treatment outcomes: converting SF-36 data into quality-adjusted life years.
Hatten AL; Gatchel RJ; Polatin PB; Stowell AW
Clin J Pain; 2006 Oct; 22(8):700-11. PubMed ID: 16988566
[TBL] [Abstract][Full Text] [Related]
18. Nationwide veterans affairs quality measure for cancer: the family assessment of treatment at end of life.
Finlay E; Shreve S; Casarett D
J Clin Oncol; 2008 Aug; 26(23):3838-44. PubMed ID: 18688050
[TBL] [Abstract][Full Text] [Related]
19. Does it matter who you are or what you gain? An experimental study of preferences for resource allocation.
Schwappach DL
Health Econ; 2003 Apr; 12(4):255-67. PubMed ID: 12652513
[TBL] [Abstract][Full Text] [Related]
20. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
Roe RH; Lass JH; Brown GC; Brown MM
Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
